SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DRS - Draft Registration Statement:
SEC Accession No. 0000950123-21-004193
Filing Date
2021-04-02
Accepted
2021-04-02 16:21:40
Documents
15

Document Format Files

Seq Description Document Type Size
1 filename1.htm DRS 1407192
2 filename2.htm EX-3.1 92454
3 filename3.htm EX-3.3 96154
4 filename4.htm EX-10.2 126639
5 filename5.htm EX-10.3 26343
6 filename6.htm EX-10.4 27718
7 GRAPHIC g137089g00v11.jpg GRAPHIC 98366
8 GRAPHIC g137089g19j70.jpg GRAPHIC 35906
9 GRAPHIC g137089g21u93.jpg GRAPHIC 100084
10 GRAPHIC g137089g25o58.jpg GRAPHIC 72910
11 GRAPHIC g137089g27v66.jpg GRAPHIC 99255
12 GRAPHIC g137089g34f15.jpg GRAPHIC 38517
13 GRAPHIC g137089g36e83.jpg GRAPHIC 73061
14 GRAPHIC g137089g88d02.jpg GRAPHIC 102786
15 GRAPHIC g137089g90n41.jpg GRAPHIC 101662
  Complete submission text file 0000950123-21-004193.txt   2761837
Mailing Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130
Business Address 3525 DEL MAR HEIGHTS RD., #332 SAN DIEGO CA 92130 (858)-223-0882
Dermata Therapeutics, Inc. (Filer) CIK: 0001853816 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DRS | Act: 33 | File No.: 377-04573 | Film No.: 21802223
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences